nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.394	0.558	CbGbCtD
Verapamil—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.222	0.313	CbGbCtD
Verapamil—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0914	0.129	CbGbCtD
Verapamil—CACNA1A—nerve—amyotrophic lateral sclerosis	0.00499	0.0636	CbGeAlD
Verapamil—CACNA1A—hindbrain—amyotrophic lateral sclerosis	0.00374	0.0476	CbGeAlD
Verapamil—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0368	CcSEcCtD
Verapamil—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0346	CcSEcCtD
Verapamil—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0316	CcSEcCtD
Verapamil—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0294	CcSEcCtD
Verapamil—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0265	CcSEcCtD
Verapamil—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0235	CcSEcCtD
Verapamil—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0232	CcSEcCtD
Verapamil—CACNA1A—brainstem—amyotrophic lateral sclerosis	0.00214	0.0273	CbGeAlD
Verapamil—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0211	CcSEcCtD
Verapamil—Injury—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0206	CcSEcCtD
Verapamil—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0196	CcSEcCtD
Verapamil—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0194	CcSEcCtD
Verapamil—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0189	CcSEcCtD
Verapamil—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0184	CcSEcCtD
Verapamil—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00177	0.018	CcSEcCtD
Verapamil—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0173	CcSEcCtD
Verapamil—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0167	CcSEcCtD
Verapamil—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0163	CcSEcCtD
Verapamil—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0159	CcSEcCtD
Verapamil—CACNB4—medulla oblongata—amyotrophic lateral sclerosis	0.00156	0.0199	CbGeAlD
Verapamil—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0157	CcSEcCtD
Verapamil—CACNA1A—medulla oblongata—amyotrophic lateral sclerosis	0.00149	0.019	CbGeAlD
Verapamil—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0151	CcSEcCtD
Verapamil—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00148	0.015	CcSEcCtD
Verapamil—CACNA1B—medulla oblongata—amyotrophic lateral sclerosis	0.00146	0.0186	CbGeAlD
Verapamil—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0144	CcSEcCtD
Verapamil—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0143	CcSEcCtD
Verapamil—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0142	CcSEcCtD
Verapamil—CACNB4—spinal cord—amyotrophic lateral sclerosis	0.0014	0.0178	CbGeAlD
Verapamil—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00137	0.014	CcSEcCtD
Verapamil—CACNA1I—cerebellum—amyotrophic lateral sclerosis	0.00134	0.0171	CbGeAlD
Verapamil—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0137	CcSEcCtD
Verapamil—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0133	CcSEcCtD
Verapamil—CACNA1B—spinal cord—amyotrophic lateral sclerosis	0.0013	0.0166	CbGeAlD
Verapamil—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0131	CcSEcCtD
Verapamil—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0131	CcSEcCtD
Verapamil—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.013	CcSEcCtD
Verapamil—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00128	0.013	CcSEcCtD
Verapamil—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0129	CcSEcCtD
Verapamil—CACNB1—medulla oblongata—amyotrophic lateral sclerosis	0.00125	0.0159	CbGeAlD
Verapamil—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00123	0.0156	CbGeAlD
Verapamil—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0124	CcSEcCtD
Verapamil—CACNB3—medulla oblongata—amyotrophic lateral sclerosis	0.0012	0.0153	CbGeAlD
Verapamil—CACNB4—nervous system—amyotrophic lateral sclerosis	0.00118	0.015	CbGeAlD
Verapamil—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0115	CcSEcCtD
Verapamil—CACNB4—central nervous system—amyotrophic lateral sclerosis	0.00113	0.0144	CbGeAlD
Verapamil—CACNA1A—nervous system—amyotrophic lateral sclerosis	0.00112	0.0143	CbGeAlD
Verapamil—CACNB1—spinal cord—amyotrophic lateral sclerosis	0.00111	0.0142	CbGeAlD
Verapamil—CACNB4—cerebellum—amyotrophic lateral sclerosis	0.00111	0.0141	CbGeAlD
Verapamil—CACNA1B—nervous system—amyotrophic lateral sclerosis	0.0011	0.014	CbGeAlD
Verapamil—CACNA1I—brain—amyotrophic lateral sclerosis	0.00109	0.0139	CbGeAlD
Verapamil—CACNA1A—central nervous system—amyotrophic lateral sclerosis	0.00108	0.0138	CbGeAlD
Verapamil—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0109	CcSEcCtD
Verapamil—CACNA1A—cerebellum—amyotrophic lateral sclerosis	0.00106	0.0135	CbGeAlD
Verapamil—CACNA1B—central nervous system—amyotrophic lateral sclerosis	0.00105	0.0134	CbGeAlD
Verapamil—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0107	CcSEcCtD
Verapamil—CACNA1B—cerebellum—amyotrophic lateral sclerosis	0.00103	0.0131	CbGeAlD
Verapamil—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0105	CcSEcCtD
Verapamil—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0104	CcSEcCtD
Verapamil—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0102	CcSEcCtD
Verapamil—Syncope—Riluzole—amyotrophic lateral sclerosis	0.001	0.0102	CcSEcCtD
Verapamil—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00099	0.0101	CcSEcCtD
Verapamil—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000984	0.01	CcSEcCtD
Verapamil—CACNA1G—nervous system—amyotrophic lateral sclerosis	0.000979	0.0125	CbGeAlD
Verapamil—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00097	0.00986	CcSEcCtD
Verapamil—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00982	CcSEcCtD
Verapamil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000953	0.00969	CcSEcCtD
Verapamil—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000953	0.00969	CcSEcCtD
Verapamil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000953	0.00969	CcSEcCtD
Verapamil—CACNA1G—central nervous system—amyotrophic lateral sclerosis	0.000943	0.012	CbGeAlD
Verapamil—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000942	0.00957	CcSEcCtD
Verapamil—CACNB1—nervous system—amyotrophic lateral sclerosis	0.000939	0.012	CbGeAlD
Verapamil—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000932	0.00947	CcSEcCtD
Verapamil—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00936	CcSEcCtD
Verapamil—CACNA1G—cerebellum—amyotrophic lateral sclerosis	0.000921	0.0117	CbGeAlD
Verapamil—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000914	0.00928	CcSEcCtD
Verapamil—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000914	0.00928	CcSEcCtD
Verapamil—Infection—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00922	CcSEcCtD
Verapamil—CACNB1—central nervous system—amyotrophic lateral sclerosis	0.000904	0.0115	CbGeAlD
Verapamil—CACNB3—nervous system—amyotrophic lateral sclerosis	0.0009	0.0115	CbGeAlD
Verapamil—Shock—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00913	CcSEcCtD
Verapamil—CACNB4—brain—amyotrophic lateral sclerosis	0.000899	0.0115	CbGeAlD
Verapamil—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00906	CcSEcCtD
Verapamil—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00898	CcSEcCtD
Verapamil—CACNB1—cerebellum—amyotrophic lateral sclerosis	0.000883	0.0113	CbGeAlD
Verapamil—CACNB3—central nervous system—amyotrophic lateral sclerosis	0.000867	0.0111	CbGeAlD
Verapamil—CACNA1A—brain—amyotrophic lateral sclerosis	0.000858	0.0109	CbGeAlD
Verapamil—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00868	CcSEcCtD
Verapamil—CACNB3—cerebellum—amyotrophic lateral sclerosis	0.000847	0.0108	CbGeAlD
Verapamil—CACNA1B—brain—amyotrophic lateral sclerosis	0.000837	0.0107	CbGeAlD
Verapamil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00846	CcSEcCtD
Verapamil—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000827	0.0084	CcSEcCtD
Verapamil—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000821	0.00834	CcSEcCtD
Verapamil—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000815	0.00828	CcSEcCtD
Verapamil—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00825	CcSEcCtD
Verapamil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00817	CcSEcCtD
Verapamil—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000788	0.008	CcSEcCtD
Verapamil—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000782	0.00794	CcSEcCtD
Verapamil—Pain—Riluzole—amyotrophic lateral sclerosis	0.000782	0.00794	CcSEcCtD
Verapamil—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000753	0.00765	CcSEcCtD
Verapamil—CACNA1G—brain—amyotrophic lateral sclerosis	0.000748	0.00954	CbGeAlD
Verapamil—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000726	0.00738	CcSEcCtD
Verapamil—CACNB1—brain—amyotrophic lateral sclerosis	0.000718	0.00915	CbGeAlD
Verapamil—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.000702	0.00895	CbGeAlD
Verapamil—CACNB3—brain—amyotrophic lateral sclerosis	0.000688	0.00877	CbGeAlD
Verapamil—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000673	0.00684	CcSEcCtD
Verapamil—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000656	0.00666	CcSEcCtD
Verapamil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000647	0.00657	CcSEcCtD
Verapamil—CACNA1H—nervous system—amyotrophic lateral sclerosis	0.000641	0.00817	CbGeAlD
Verapamil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000625	0.00635	CcSEcCtD
Verapamil—CACNB2—nervous system—amyotrophic lateral sclerosis	0.000605	0.00771	CbGeAlD
Verapamil—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000604	0.00614	CcSEcCtD
Verapamil—CACNA1H—cerebellum—amyotrophic lateral sclerosis	0.000603	0.00768	CbGeAlD
Verapamil—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000591	0.00753	CbGeAlD
Verapamil—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.000588	0.0075	CbGeAlD
Verapamil—CACNB2—central nervous system—amyotrophic lateral sclerosis	0.000582	0.00742	CbGeAlD
Verapamil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000581	0.0059	CcSEcCtD
Verapamil—Rash—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00585	CcSEcCtD
Verapamil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00585	CcSEcCtD
Verapamil—KCNJ11—nervous system—amyotrophic lateral sclerosis	0.000574	0.00732	CbGeAlD
Verapamil—Headache—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00582	CcSEcCtD
Verapamil—CACNB2—cerebellum—amyotrophic lateral sclerosis	0.000569	0.00726	CbGeAlD
Verapamil—KCNJ11—central nervous system—amyotrophic lateral sclerosis	0.000553	0.00705	CbGeAlD
Verapamil—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00551	CcSEcCtD
Verapamil—KCNJ11—cerebellum—amyotrophic lateral sclerosis	0.00054	0.00689	CbGeAlD
Verapamil—CACNA1D—nervous system—amyotrophic lateral sclerosis	0.000529	0.00674	CbGeAlD
Verapamil—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.000524	0.00668	CbGeAlD
Verapamil—CACNA1D—central nervous system—amyotrophic lateral sclerosis	0.000509	0.00649	CbGeAlD
Verapamil—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.000507	0.00646	CbGeAlD
Verapamil—CACNA1D—cerebellum—amyotrophic lateral sclerosis	0.000498	0.00634	CbGeAlD
Verapamil—SLC22A4—spinal cord—amyotrophic lateral sclerosis	0.000493	0.00628	CbGeAlD
Verapamil—CACNA1H—brain—amyotrophic lateral sclerosis	0.00049	0.00624	CbGeAlD
Verapamil—CACNA1C—nervous system—amyotrophic lateral sclerosis	0.000488	0.00622	CbGeAlD
Verapamil—SCN5A—nervous system—amyotrophic lateral sclerosis	0.000473	0.00603	CbGeAlD
Verapamil—CACNA1C—central nervous system—amyotrophic lateral sclerosis	0.00047	0.00599	CbGeAlD
Verapamil—CACNB2—brain—amyotrophic lateral sclerosis	0.000462	0.00589	CbGeAlD
Verapamil—CACNA1C—cerebellum—amyotrophic lateral sclerosis	0.000459	0.00586	CbGeAlD
Verapamil—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.000455	0.0058	CbGeAlD
Verapamil—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.000452	0.00576	CbGeAlD
Verapamil—ABCC3—nervous system—amyotrophic lateral sclerosis	0.000444	0.00566	CbGeAlD
Verapamil—KCNJ11—brain—amyotrophic lateral sclerosis	0.000439	0.00559	CbGeAlD
Verapamil—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.000437	0.00557	CbGeAlD
Verapamil—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000427	0.00545	CbGeAlD
Verapamil—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.000416	0.0053	CbGeAlD
Verapamil—CACNA1D—brain—amyotrophic lateral sclerosis	0.000404	0.00515	CbGeAlD
Verapamil—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000396	0.00504	CbGeAlD
Verapamil—SLC22A4—cerebellum—amyotrophic lateral sclerosis	0.000391	0.00498	CbGeAlD
Verapamil—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.000387	0.00493	CbGeAlD
Verapamil—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000381	0.00485	CbGeAlD
Verapamil—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000381	0.00485	CbGeAlD
Verapamil—CACNA1C—brain—amyotrophic lateral sclerosis	0.000373	0.00476	CbGeAlD
Verapamil—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.000368	0.00469	CbGeAlD
Verapamil—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.000367	0.00467	CbGeAlD
Verapamil—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000367	0.00467	CbGeAlD
Verapamil—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.000366	0.00466	CbGeAlD
Verapamil—SCN5A—brain—amyotrophic lateral sclerosis	0.000362	0.00461	CbGeAlD
Verapamil—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000358	0.00457	CbGeAlD
Verapamil—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000354	0.00452	CbGeAlD
Verapamil—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000353	0.0045	CbGeAlD
Verapamil—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000345	0.0044	CbGeAlD
Verapamil—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000344	0.00439	CbGeAlD
Verapamil—ABCC3—brain—amyotrophic lateral sclerosis	0.000339	0.00433	CbGeAlD
Verapamil—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000339	0.00432	CbGeAlD
Verapamil—ABCC10—brain—amyotrophic lateral sclerosis	0.000338	0.00431	CbGeAlD
Verapamil—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.000326	0.00416	CbGeAlD
Verapamil—SLC22A4—brain—amyotrophic lateral sclerosis	0.000317	0.00405	CbGeAlD
Verapamil—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000307	0.00391	CbGeAlD
Verapamil—SLC22A1—brain—amyotrophic lateral sclerosis	0.000302	0.00385	CbGeAlD
Verapamil—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000294	0.00375	CbGeAlD
Verapamil—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000291	0.00371	CbGeAlD
Verapamil—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000291	0.00371	CbGeAlD
Verapamil—SLC6A4—brain—amyotrophic lateral sclerosis	0.000281	0.00358	CbGeAlD
Verapamil—ABCC4—brain—amyotrophic lateral sclerosis	0.00028	0.00357	CbGeAlD
Verapamil—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.00028	0.00357	CbGeAlD
Verapamil—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000274	0.00349	CbGeAlD
Verapamil—ABCB1—embryo—amyotrophic lateral sclerosis	0.000266	0.00339	CbGeAlD
Verapamil—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.000259	0.0033	CbGeAlD
Verapamil—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000243	0.0031	CbGeAlD
Verapamil—ABCC1—brain—amyotrophic lateral sclerosis	0.000239	0.00304	CbGeAlD
Verapamil—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000239	0.00304	CbGeAlD
Verapamil—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00023	0.00293	CbGeAlD
Verapamil—KCNH2—brain—amyotrophic lateral sclerosis	0.000222	0.00283	CbGeAlD
Verapamil—SLC22A5—brain—amyotrophic lateral sclerosis	0.00021	0.00268	CbGeAlD
Verapamil—CYP2C8—brain—amyotrophic lateral sclerosis	0.000203	0.00259	CbGeAlD
Verapamil—ABCG2—brain—amyotrophic lateral sclerosis	0.000198	0.00252	CbGeAlD
Verapamil—CYP2B6—brain—amyotrophic lateral sclerosis	0.000182	0.00233	CbGeAlD
Verapamil—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00018	0.0023	CbGeAlD
Verapamil—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000177	0.00226	CbGeAlD
Verapamil—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000174	0.00221	CbGeAlD
Verapamil—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000171	0.00218	CbGeAlD
Verapamil—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00017	0.00216	CbGeAlD
Verapamil—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000167	0.00213	CbGeAlD
Verapamil—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000151	0.00193	CbGeAlD
Verapamil—CYP2D6—brain—amyotrophic lateral sclerosis	0.000136	0.00173	CbGeAlD
Verapamil—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000128	0.00163	CbGeAlD
Verapamil—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000123	0.00157	CbGeAlD
Verapamil—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00012	0.00153	CbGeAlD
Verapamil—ABCB1—brain—amyotrophic lateral sclerosis	9.75e-05	0.00124	CbGeAlD
Verapamil—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.06e-05	0.000264	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	3.02e-05	0.000261	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.99e-05	0.000258	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.98e-05	0.000258	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.97e-05	0.000257	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.97e-05	0.000256	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.94e-05	0.000254	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.93e-05	0.000253	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000252	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.9e-05	0.000251	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.9e-05	0.000251	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—MMP9—amyotrophic lateral sclerosis	2.9e-05	0.000251	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	2.88e-05	0.000249	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.88e-05	0.000249	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.87e-05	0.000248	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—APOE—amyotrophic lateral sclerosis	2.87e-05	0.000248	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.85e-05	0.000246	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.83e-05	0.000244	CbGpPWpGaD
Verapamil—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.83e-05	0.000244	CbGpPWpGaD
Verapamil—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.79e-05	0.000241	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.78e-05	0.00024	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.78e-05	0.00024	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.76e-05	0.000238	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.75e-05	0.000238	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.74e-05	0.000237	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	2.73e-05	0.000235	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.71e-05	0.000234	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.71e-05	0.000234	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-05	0.000233	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.69e-05	0.000233	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.67e-05	0.00023	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.66e-05	0.00023	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.65e-05	0.000229	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.63e-05	0.000228	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.63e-05	0.000227	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.63e-05	0.000227	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.61e-05	0.000225	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.61e-05	0.000225	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.6e-05	0.000225	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.59e-05	0.000224	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.56e-05	0.000221	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.56e-05	0.000221	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.55e-05	0.00022	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.54e-05	0.00022	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	2.54e-05	0.000219	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.54e-05	0.000219	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.54e-05	0.000219	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.54e-05	0.000219	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	2.52e-05	0.000217	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.5e-05	0.000216	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.49e-05	0.000215	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.49e-05	0.000215	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.48e-05	0.000214	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.41e-05	0.000208	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.41e-05	0.000208	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.4e-05	0.000207	CbGpPWpGaD
Verapamil—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	2.39e-05	0.000206	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.37e-05	0.000205	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.36e-05	0.000204	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.36e-05	0.000204	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.36e-05	0.000204	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.35e-05	0.000203	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.34e-05	0.000202	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.34e-05	0.000202	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.32e-05	0.0002	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.31e-05	0.000199	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.25e-05	0.000195	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.25e-05	0.000194	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.24e-05	0.000193	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.22e-05	0.000192	CbGpPWpGaD
Verapamil—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.18e-05	0.000188	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.18e-05	0.000188	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.17e-05	0.000188	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.17e-05	0.000187	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.17e-05	0.000187	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.17e-05	0.000187	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.16e-05	0.000187	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.16e-05	0.000186	CbGpPWpGaD
Verapamil—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.15e-05	0.000186	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.14e-05	0.000185	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.12e-05	0.000183	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.09e-05	0.000181	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.08e-05	0.00018	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.08e-05	0.00018	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.07e-05	0.000179	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	2.07e-05	0.000178	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.06e-05	0.000178	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.05e-05	0.000177	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.04e-05	0.000177	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.03e-05	0.000176	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.03e-05	0.000175	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.02e-05	0.000174	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.000174	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.01e-05	0.000174	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.000173	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.98e-05	0.000171	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.97e-05	0.00017	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.97e-05	0.00017	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.97e-05	0.00017	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.96e-05	0.000169	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.92e-05	0.000166	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.91e-05	0.000165	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.9e-05	0.000164	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.89e-05	0.000163	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.88e-05	0.000162	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.86e-05	0.000161	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.86e-05	0.000161	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.85e-05	0.00016	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-05	0.00016	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.84e-05	0.000159	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.83e-05	0.000158	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.82e-05	0.000157	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.81e-05	0.000157	CbGpPWpGaD
Verapamil—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	1.74e-05	0.00015	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.73e-05	0.00015	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.71e-05	0.000147	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.69e-05	0.000146	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.69e-05	0.000146	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.67e-05	0.000144	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.67e-05	0.000144	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.67e-05	0.000144	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.67e-05	0.000144	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—APOE—amyotrophic lateral sclerosis	1.65e-05	0.000142	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.65e-05	0.000142	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.62e-05	0.00014	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.57e-05	0.000136	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—APOE—amyotrophic lateral sclerosis	1.57e-05	0.000136	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.57e-05	0.000135	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.57e-05	0.000135	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—APOE—amyotrophic lateral sclerosis	1.56e-05	0.000135	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000135	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.54e-05	0.000133	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000133	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.53e-05	0.000132	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000132	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000132	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.000129	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	0.000129	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.49e-05	0.000128	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.49e-05	0.000128	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.48e-05	0.000128	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000124	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.42e-05	0.000123	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.41e-05	0.000122	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.41e-05	0.000121	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.4e-05	0.000121	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.39e-05	0.00012	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.37e-05	0.000119	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—APOE—amyotrophic lateral sclerosis	1.37e-05	0.000118	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.34e-05	0.000115	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.33e-05	0.000115	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.3e-05	0.000112	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.29e-05	0.000112	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.29e-05	0.000112	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000111	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.00011	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-05	0.000109	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	1.23e-05	0.000106	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000104	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.21e-05	0.000104	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.19e-05	0.000103	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000102	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000101	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	1.16e-05	0.0001	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	9.97e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	1.15e-05	9.93e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	9.75e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.13e-05	9.73e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.12e-05	9.68e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	9.6e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.11e-05	9.59e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.1e-05	9.46e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.08e-05	9.3e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.07e-05	9.24e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-05	9.23e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.06e-05	9.17e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	9.1e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.05e-05	9.09e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.03e-05	8.93e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	8.89e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	8.81e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1e-05	8.67e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.98e-06	8.62e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	9.62e-06	8.31e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.6e-06	8.3e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.49e-06	8.2e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.39e-06	8.11e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.16e-06	7.91e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	9.15e-06	7.9e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	9e-06	7.77e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.78e-06	7.58e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.65e-06	7.47e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	8.47e-06	7.32e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.45e-06	7.3e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.42e-06	7.27e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	8.39e-06	7.25e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.21e-06	7.09e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.21e-06	7.09e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.09e-06	6.99e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.03e-06	6.93e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	7.87e-06	6.8e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.81e-06	6.75e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.55e-06	6.52e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.38e-06	6.37e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.33e-06	6.33e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.22e-06	6.23e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.95e-06	6e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.94e-06	6e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.59e-06	5.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.58e-06	5.68e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.39e-06	5.52e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.27e-06	5.41e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	6.21e-06	5.36e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.2e-06	5.36e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.07e-06	5.24e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.06e-06	5.23e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.8e-06	5.01e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.75e-06	4.97e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.71e-06	4.93e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.7e-06	4.93e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.66e-06	4.89e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.62e-06	4.86e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.57e-06	4.81e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.35e-06	4.62e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.26e-06	4.54e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.24e-06	4.53e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.2e-06	4.49e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.83e-06	4.18e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.69e-06	4.05e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.58e-06	3.96e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.44e-06	3.84e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.31e-06	3.73e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.28e-06	3.69e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.25e-06	3.67e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.16e-06	3.59e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.73e-06	3.22e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.66e-06	3.16e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.6e-06	3.11e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.43e-06	2.96e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.21e-06	2.78e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.14e-06	2.71e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.96e-06	2.55e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.93e-06	2.53e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.82e-06	2.44e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.5e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.93e-06	1.67e-05	CbGpPWpGaD
